Gilead Seeks High Court Review Of Double-Patenting Row
Gilead Sciences Inc. has asked the U.S. Supreme Court to take up its case with Natco Pharma Ltd. over its planned generic version of Tamiflu, claiming the Federal Circuit's finding that...To view the full article, register now.
Already a subscriber? Click here to view full article